Dr Mukherjee's current interests are in colorectal and breast cancer pathology and biomarkers/molecular signatures of metastases and response to therapy. He has extensive experience of breast, ovarian and colorectal cancer research. This includes molecular/immunological markers of prognosis and prediction of response to therapeutic agents. He has also a strong background in researching the mechanism of action of novel drugs (including anti-angiogenic agents) and validation of drug targets used in cancer therapy. He is also interested in inflammatory bowel diseases especially novel molecular techniques aiding pathological diagnosis.